Phase 4 Open-labeled Study to Compare the Anti-depressive Efficacy Between Mirtazapine and Psychotherapy for Patients With Interferon-related Depression During Antiviral Therapy for Hepatitis C.

Trial Profile

Phase 4 Open-labeled Study to Compare the Anti-depressive Efficacy Between Mirtazapine and Psychotherapy for Patients With Interferon-related Depression During Antiviral Therapy for Hepatitis C.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 May 2017

At a glance

  • Drugs Mirtazapine (Primary)
  • Indications Depression
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Jun 2018.
    • 27 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 18 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top